IDLC Growth Fund (IGF) vs Shanta First Income Unit Fund (SFIUF)

Over the last 5 years, as a one-time investment, IDLC Growth Fund (IGF) returned 4.88% a year and Shanta First Income Unit Fund (SFIUF) returned -1.54% a year, both with cash dividends reinvested, based on NAV history through 16 Nov 2026.

Both figures are one-time (lump sum) total returns with cash dividends reinvested, measured over the same months from each fund’s published NAV history. Past performance does not predict the future.

IDLC Growth Fund (IGF)Shanta First Income Unit Fund (SFIUF)
TypeGrowthGrowth
Asset managerIDLC Asset Management Limited (IDLC AML)Shanta Asset Management Limited (SAML)
Fund size৳96 cr৳83 cr
Tracked sinceJun 2019Mar 2018
One-time, last 1 year+11.03%+12.67%
One-time, per year, last 3 years+8.82%-1.23%
One-time, per year, last 5 years+4.88%-1.54%
Management fee2.50% down to 1.00% per year (tiered by fund size)2.50% down to 1.00% per year (tiered by fund size)
Exit loadExit load 3% of Investor's Sale Price if surrendered before 90 calendar days; no entry loadSIP cancelled before 2 years: 1%; otherwise none
Minimum (one time)500 units individual / 5,000 units institution, at the buy price500 units individual / 5,000 units institution; SIP from BDT 1,000

How they differ

What they hold

IDLC Growth Fund (IGF)

Statement of 30 Sep 2026, by market value

Listed equity 83.52%, Cash at bank 6.33%, Government treasury bond 5.00%

  1. BRAC Bank14.88%
  2. Beximco Pharmaceuticals11.23%
  3. Square Pharmaceuticals9.89%
  4. Robi Axiata9.39%
  5. Jamuna Bank8.97%

Shanta First Income Unit Fund (SFIUF)

Statement of 30 Sep 2026, by cost value

Listed equities 52.12%, Cash at bank 19.73%, Corporate perpetual bonds 16.18%

  1. Berger Paints Bangladesh9.35%
  2. BRAC Bank8.69%
  3. Square Pharmaceuticals8.66%
  4. Renata7.77%
  5. Beximco Pharmaceuticals6.84%

Stocks both funds name among their largest holdings: BRAC Bank (14.88% of IDLC Growth Fund (IGF), 8.69% of Shanta First Income Unit Fund (SFIUF)); Square Pharmaceuticals (9.89% of IDLC Growth Fund (IGF), 8.66% of Shanta First Income Unit Fund (SFIUF)); Beximco Pharmaceuticals (11.23% of IDLC Growth Fund (IGF), 6.84% of Shanta First Income Unit Fund (SFIUF)); Renata (4.69% of IDLC Growth Fund (IGF), 7.77% of Shanta First Income Unit Fund (SFIUF)); British American Tobacco Bangladesh (4.67% of IDLC Growth Fund (IGF), 4.95% of Shanta First Income Unit Fund (SFIUF)).

From each fund manager’s own portfolio statement. Each fund has its own statement date and valuation basis, so treat the weights as a snapshot, not a live position.

Compare these two with the full tool

Rolling returns, path risk, holdings overlap and a growth chart, on any period you choose.

Open IDLC Growth Fund (IGF) · Open Shanta First Income Unit Fund (SFIUF)